European Hematology Association (EHA) shared a post on X: .
“New course available: Myeloid Neoplasms: Translating Omics to Diagnostic Tests.
Professor Mead addresses prognostic factors in myeloid malignancies and stratifying patient outcomes, while Professor Porkka highlights how big data could give prognostic indications.”
Additional details.
Source: EHA/X